Download:
pdf |
pdfCenters for Medicare & Medicaid
Services
CMS eXpedited Life Cycle (XLC)
Medicaid and CHIP Program (MACPro)
CQM 2017 - Follow-Up Care for Children
Prescribed Attention-Deficit/Hyperactivity
Disorder (ADHD) Medication (ADD) Core Measure
PRA Document
Version 1.0
08/24/2017
Document Number: 260-QSSI-MACPro-PRA-CQM2017-ADD-D
Contract Number: HHSM-500-2007-00024I: HHSM-500-T0014
CMS XLC
Table of Contents
Table of Contents
1. Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity
Disorder (ADHD) Medication (ADD) Screenshots ................................................. 1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
1.9
Measurement Specifications – Path 1 ............................................................. 1
Measurement Specifications – Path 2 ............................................................. 1
Data Source .................................................................................................... 1
Performance Measure - Path 1 ....................................................................... 2
Performance Measure - Path 2 ....................................................................... 2
Deviations from Measure Specifications – Screenshot 1 ................................ 3
Deviations from Measure Specifications – Screenshot 2 ................................ 3
Optional Measure Stratification – Screenshot 1 .............................................. 4
Optional Measure Stratification – Screenshot 2 .............................................. 4
Appendix A: Acronyms ................................................................................................. 5
List of Figures
Figure 1: Measurement Specifications – Path 1 .............................................................. 1
Figure 2: Measurement Specifications – Path 2 .............................................................. 1
Figure 3 : Data Source .................................................................................................... 1
Figure 4: Performance Measure - Path 1 ........................................................................ 2
Figure 5: Performance Measure - Path 2 ........................................................................ 2
Figure 6: Deviations from Measure Specifications – Screenshot 1 ................................. 3
Figure 7 : Deviations from Measure Specifications – Screenshot 2 ................................ 3
Figure 8 : Optional Measure Stratification – Screenshot 1 .............................................. 4
Figure 9: Optional Measure Stratification – Screenshot 2 ............................................... 4
List of Tables
No table of figures entries found.
CQM 2017 - Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication (ADD) Core Measure PRA
Document Version 1.0
i
08/24/2017
CMS XLC
Measurement Specifications – Path 1
1. Follow-Up Care for Children Prescribed AttentionDeficit/Hyperactivity Disorder (ADHD) Medication
(ADD) Screenshots
1.1
Measurement Specifications – Path 1
Figure 1: Measurement Specifications – Path 1
1.2
Measurement Specifications – Path 2
Figure 2: Measurement Specifications – Path 2
1.3
Data Source
Figure 3 : Data Source
CQM 2017 - Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication (ADD) Core Measure PRA
Document Version 1.0
1
08/24/2017
CMS XLC
1.4
Performance Measure - Path 1
Performance Measure - Path 1
Figure 4: Performance Measure - Path 1
1.5
Performance Measure - Path 2
Figure 5: Performance Measure - Path 2
CQM 2017 - Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication (ADD) Core Measure PRA
Document Version 1.0
2
08/24/2017
CMS XLC
1.6
Deviations from Measure Specifications – Screenshot 1
Deviations from Measure Specifications – Screenshot 1
Figure 6: Deviations from Measure Specifications – Screenshot 1
1.7
Deviations from Measure Specifications – Screenshot 2
Figure 7 : Deviations from Measure Specifications – Screenshot 2
CQM 2017 - Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication (ADD) Core Measure PRA
Document Version 1.0
3
08/24/2017
CMS XLC
1.8
Optional Measure Stratification – Screenshot 1
Optional Measure Stratification – Screenshot 1
Note: Same N/D/R sets are displayed under each of the stratification categories
Figure 8 : Optional Measure Stratification – Screenshot 1
1.9
Optional Measure Stratification – Screenshot 2
Figure 9: Optional Measure Stratification – Screenshot 2
CQM 2017 - Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication (ADD) Core Measure PRA
Document Version 1.0
4
08/24/2017
CMS XLC
Optional Measure Stratification – Screenshot 2
Appendix A: Acronyms
Table 1: Acronyms
Acronym
Definition
CQM
Child Quality Measures
PRA
Paperwork Reduction Act of 1995
CQM 2017 - Follow-Up Care for Children Prescribed Attention-Deficit/Hyperactivity Disorder (ADHD) Medication (ADD) Core Measure PRA
Document Version 1.0
5
08/24/2017
File Type | application/pdf |
File Modified | 2017-09-07 |
File Created | 2017-09-07 |